BAYER A.G. (BAYZF)
Clinical trial NCT04122976 updates: 1. completion date: 2026-12-30 → 2026-10-07 2. primary completion date: 2026-12-30 → 2026-07-07
Clinical trial NCT04122976 updates: 1. completion date: 2026-12-30 → 2026-10-07 2. primary completion date: 2026-12-30 → 2026-07-07
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical